Targeting DNA repair mechanisms such as PARP attenuated gliomagenesis [55] and inhibition of DNA repair protein such as RAD51 in GBM cells resulted in greater TMZ sensitivity [56]. The gene discussed is XRCC6P5; the disease is glioblastoma.